Midazolam

Especificaciones

59467-70-8Número CAS

261-774-5Número CE

8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepineNombre IUPAC

C18H13ClFN3Fórmula química

325.8 g/molPeso molecular

midazolam; 59467-70-8; Buccolam; Midazolamum; 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine; mezolam; Nayzilam; Midazolam civ; USL261; R60L0SM5BC; USL-261; 8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin; 8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine; CHEBI:6931; DTXSID5023320; 4H-Imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-; 4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-; 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo(1,5-a)(1,4)benzodiazepine; Epistatus; Maleate, Midazolam; 12-chloro-9-(2-fluorophenyl)-3-methyl-2,4,8-triazatricyclo(8.4.0.0^(2,6))tetradeca-1(14),3,5,8,10,12-hexaene; 12-chloro-9-(2-fluorophenyl)-3-methyl-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,8,10,12-hexaene; RefChem:6038; Hydrochloride, Midazolam; Midazolam in Sodium Chloride; Midazolam Injection, 10 mg; DTXCID503320; N05CD08; Ro 213981; Ro 21 3981; MIDAZOLAM IN 0.8% SODIUM CHLORIDE; MIDAZOLAM IN 0.9% SODIUM CHLORIDE; 12-chloro-9-(2-fluorophenyl)-3-methyl-2,4,8-triazatricyclo(8.4.0.02,6)tetradeca-1(10),3,5,8,11,13-hexaene; 261-774-5; Dormicum; Versed; Midazolamum [INN-Latin]; Midazolam Base; DEA No. 2884; Ro 21-3981; CHEMBL655; 8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine; Dazolam; Midazolam (1.0 mg/mL in methanol); Dormicum (TN); 12-chloro-9-(2-fluorophenyl)-3-methyl-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene; NCGC00168254-01; EINECS 261-774-5; UNII-R60L0SM5BC; BRN 0625572; Medazolam; Midazolam [USP:INN:BAN:JAN]; Buccolam (TN); Nayzilam (TN); 08J; Versed (Salt/Mix); Dormonid (Salt/Mix); Hypnovel (Salt/Mix); Flormidal (Salt/Mix); MIDAZOLAM [INN]; MIDAZOLAM [JAN]; MIDAZOLAM [MI]; MIDAZOLAM [VANDF]; Midazolam CRS - * psy; MIDAZOLAM [MART.]; MIDAZOLAM [WHO-DD]; Midazolam (JAN/USP/INN); SCHEMBL35061; BIDD:GT0647; Midazolam hydrochloride, solid; Midazolam, 1mg/ml in Methanol; GTPL3342; MIDAZOLAM [ORANGE BOOK]; MIDAZOLAM CIV [USP-RS]; MIDAZOLAM [EP MONOGRAPH]; SCHEMBL29357425; SCHEMBL29480459; SCHEMBL29565146; BDBM21363; HSDB 6751; MIDAZOLAM [USP MONOGRAPH]; Midazolam 0.1 mg/ml in Methanol; Midazolam 1.0 mg/ml in Methanol; USL261 (nasal spray formulation); HY-B0676; AKOS015842580; DB00683; FM25999; 4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate; DB-015270; NS00000476; C07524; D00550; Q423071; Midazolam for system suitability CRS - * psy (Midazolam); Midazolam hydrochloride, United States Pharmacopeia (USP) Reference Standard; 4H-IMIDAZO(1,5-A)(1,4)BENZODIAZEPINE, 8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYLSinónimos